Scientists at the lab of Professor Hilal Lashuel at EPFL have identified a new enzyme called “TBK1” who plays a central role in regulating the degradation and clearance of the huntingtin protein and introduces chemical modifications that block its aggregation. “We believe that this represents a viable target for the development of possible treatment of Huntington’s disease,” says Lashuel.
- Satellite images confirm uneven impact of climate change
- Understanding traditional Chinese medicine can help protect species
- Scientists claim controversial results of comets observations are consistent
- The smell of cooperation
- Princeton scientists solve the mystery behind an enigmatic organelle, the pyrenoid